ATE79549T1 - Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel. - Google Patents

Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.

Info

Publication number
ATE79549T1
ATE79549T1 AT88905521T AT88905521T ATE79549T1 AT E79549 T1 ATE79549 T1 AT E79549T1 AT 88905521 T AT88905521 T AT 88905521T AT 88905521 T AT88905521 T AT 88905521T AT E79549 T1 ATE79549 T1 AT E79549T1
Authority
AT
Austria
Prior art keywords
cough
antihistaminic
sedative
cold
cold remedies
Prior art date
Application number
AT88905521T
Other languages
English (en)
Inventor
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Original Assignee
Analgesic Associates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22024247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE79549(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Analgesic Associates filed Critical Analgesic Associates
Application granted granted Critical
Publication of ATE79549T1 publication Critical patent/ATE79549T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
AT88905521T 1987-06-08 1988-06-06 Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel. ATE79549T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/059,635 US4829064A (en) 1987-06-08 1987-06-08 Cough/cold mixtures comprising non-sedating antihistamine drugs
PCT/US1988/001835 WO1988009656A1 (en) 1987-06-08 1988-06-06 Cough/cold mixtures comprising non-sedating antihistamine drugs
EP88905521A EP0316434B2 (de) 1987-06-08 1988-06-06 Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel

Publications (1)

Publication Number Publication Date
ATE79549T1 true ATE79549T1 (de) 1992-09-15

Family

ID=22024247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88905521T ATE79549T1 (de) 1987-06-08 1988-06-06 Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.

Country Status (7)

Country Link
US (1) US4829064A (de)
EP (1) EP0316434B2 (de)
AT (1) ATE79549T1 (de)
AU (1) AU618010B2 (de)
CA (2) CA1313136C (de)
DE (1) DE3873879T2 (de)
WO (1) WO1988009656A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
EP0421825A1 (de) * 1989-08-11 1991-04-10 Kadem Farmaseutiese Produktie B.K. Paracetamol enthaltende Lösungen
US5250529A (en) * 1990-02-08 1993-10-05 Kos Pharmaceuticals, Inc. Method alleviating migraine headache with mast cell degranulation blocking agents
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
KR100243956B1 (ko) 1991-09-06 2000-03-02 랄프 알. 팔로 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
IT1255639B (it) * 1992-07-30 1995-11-09 Uso dell'oxatomide come agente antitosse
EP1688142A1 (de) † 1992-08-03 2006-08-09 Sepracor Inc. Terfenadin-Carboxylat und die Behandlung von Hautreizung
ES2128556T3 (es) * 1992-09-24 1999-05-16 Sepracor Inc Tratamiento transdermico de la urticaria usando (+)-cetirizina opticamente pura.
ES2107235T3 (es) * 1993-06-14 1997-11-16 Janssen Pharmaceutica Nv Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
US5906747A (en) * 1995-11-13 1999-05-25 Biosepra Inc. Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
WO1998052566A1 (en) * 1997-05-21 1998-11-26 Warner-Lambert Company Non-sedating acrivastine preparation
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
PE20001070A1 (es) * 1998-09-10 2000-10-19 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
CO5200779A1 (es) * 2000-03-30 2002-09-27 Schering Corp Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos
ES2170008B1 (es) * 2000-08-25 2003-05-01 Soc Es Carburos Metalicos Sa Procedimiento para la precipitacion de particulas solidas finamente divididas.
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
CZ292874B6 (cs) * 2002-01-30 2003-12-17 Léčiva, A. S. Farmaceutický prostředek k ošetření akutních bolestí
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US20050020608A1 (en) * 2003-03-25 2005-01-27 Dr. Reddy's Laboratories Limited Crystalline cetirizine monohydrochloride
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP5607291B2 (ja) * 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
DOP2006000274A (es) 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
ES2590604T3 (es) * 2008-01-04 2016-11-22 Schabar Research Associates Llc Composición que comprende un analgésico y un antihistamínico
CN103446587A (zh) * 2011-12-28 2013-12-18 汪明 肥大细胞抑制剂在制备抗流感病毒感染药物中的应用
HRP20220112T1 (hr) 2013-12-24 2022-04-15 Virginia Commonwealth University Upotreba oksidacijskog sulfata kolesterola (ocs) za liječenje akutne insuficijencije jetre
KR20230051164A (ko) 2020-07-15 2023-04-17 샤바르 리서치 어소시에이츠 엘엘씨 급성 통증의 치료 및 속쓰림의 중증도 및/또는 위험의 감소를 위한 이부프로펜 및 파모티딘으로 구성된 단위 경구 투여 조성물
US12514846B2 (en) 2020-07-15 2026-01-06 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466960A (en) * 1983-10-18 1984-08-21 Thompson Medical Co., Inc. Analgesic-diuretic compositions
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
DE3873879D1 (de) 1992-09-24
EP0316434A1 (de) 1989-05-24
WO1988009656A1 (en) 1988-12-15
CA1318851C (en) 1993-06-08
US4829064A (en) 1989-05-09
EP0316434A4 (de) 1989-10-16
CA1313136C (en) 1993-01-26
DE3873879T2 (de) 1993-01-14
EP0316434B2 (de) 1999-06-16
EP0316434B1 (de) 1992-08-19
AU618010B2 (en) 1991-12-12
AU1948488A (en) 1989-01-04

Similar Documents

Publication Publication Date Title
ATE79549T1 (de) Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
DE3854518D1 (de) Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
US4552899B1 (de)
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
Pierpoint Salicylic acid and its derivatives in plants: medicines, metabolites and messenger molecules
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
NO880904L (no) Farmasoeytisk tablett, farmasoeytisk granulat og fremgangsmaate for deres fremstilling.
ATE145551T1 (de) Brausedosisform sowie verfahren zu deren verabreichung
PH29940A (en) Stable'extended release oral dosage composition comprising loratadine and pseudoephedrine
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
MX9405219A (es) Nueva formulacion farmaceutica.
ES2079485T3 (es) Composiciones farmaceuticas y un dispositivo para administrar las mismas.
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
CO5031291A1 (es) Composicion farmaceutica
DE69727494D1 (de) Tablette
NO983926L (no) Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
ES2036670T3 (es) Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.
ES2093779T3 (es) Formulacion farmaceutica que contiene diritromicina.
IT1217797B (it) Composizioni erbicide a base di clomazone e metodi di impiego implicanto una maggiore tolleranza nel caso di colture di mais ed altre colture
ES1000119Y (es) Una tableta farmaceutica para administracion oral
AR023464A1 (es) Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
TR199901958T2 (xx) �nfertiliteye kar�� ve fertiliteyi art�rmak i�in bir ila�.
TR199801728A2 (xx) Bir ilac�n �retimi i�in sodyum-hidrojen-de�i�tiricisi �nleyicilerinin kullan�m�.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties